Healthtech News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests
NewsDealsSocialBlogsVideosPodcasts
HealthtechNewsUltrahuman Bets on Redesigned Smart Ring to Win Back U.S. Market After Oura Dispute
Ultrahuman Bets on Redesigned Smart Ring to Win Back U.S. Market After Oura Dispute
HealthTechConsumer TechHardware

Ultrahuman Bets on Redesigned Smart Ring to Win Back U.S. Market After Oura Dispute

•February 27, 2026
0
TechCrunch – Biotech & Health
TechCrunch – Biotech & Health•Feb 27, 2026

Why It Matters

Regaining U.S. market access is critical because the region represents nearly half of Ultrahuman’s active user base, and the Ring Pro’s enhancements could re‑establish its competitive edge against Oura. The move also signals how hardware firms can leverage AI and design pivots to offset legal setbacks.

Key Takeaways

  • •Ring Pro offers 15‑day battery, priced $479.
  • •U.S. market 45% of users, disrupted by Oura patent.
  • •Jade AI provides real‑time health insights, no subscription.
  • •Ultrahuman’s 2025 revenue $150 M, 16% from subscriptions.
  • •Holds ~25% global smart‑ring market share.

Pulse Analysis

The smart‑ring category is entering a pivotal growth phase, with global shipments up 80% year‑over‑year in 2025. Oura still dominates, but Ultrahuman’s second‑place position is bolstered by a redesign that tackles the battery‑life and sensor‑accuracy pain points that have limited adoption of earlier models. By filing a new design and securing customs clearance, Ultrahuman demonstrates a strategic use of product iteration to navigate patent barriers, a tactic increasingly common among wearable startups facing intense IP battles.

Ring Pro’s hardware upgrades—dual‑core processor, revamped heart‑rate architecture, and a 250‑day data buffer—directly address the core metrics investors watch: data fidelity, on‑device processing, and user retention. Coupled with Jade’s real‑time biointelligence, the ecosystem shifts from retrospective analytics to proactive health guidance, a differentiator that could attract health‑conscious consumers, especially women who now comprise 68% of the user base. The absence of a subscription fee for Jade lowers friction, while ancillary services like PowerPlugs and Blood Vision continue to generate recurring revenue, accounting for 16% of total sales.

Financially, Ultrahuman’s $150 million run rate and profitability signal resilience despite litigation costs and narrower margins. Holding roughly a quarter of the global smart‑ring market and expanding in the UK, Canada, Australia, and India, the company is well‑positioned to capitalize on the projected 30% YoY shipment growth. Successful U.S. re‑entry will be a litmus test for its turnaround strategy; clearance of the Ring Pro could restore a critical revenue stream and reinforce investor confidence in a sector where design agility and AI integration are becoming decisive competitive levers.

Ultrahuman bets on redesigned smart ring to win back U.S. market after Oura dispute

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...